Thyrocare Technologies Limited (BOM:539871)
India · Delayed Price · Currency is INR 579.15
-11.05 (-1.87%)
At close: Jul 31, 2026
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 92.18 billion as of July 31, 2026. Its market cap has increased by 33.84% in one year.
Market Cap
92.18B
Enterprise Value
90.79B
Revenue
8.76B
Ranking
n/a
PE Ratio
52.43
Stock Price
579.15
ChartMarket Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 92.18B, an increase of 177.64%. That is a compound annual growth rate of 10.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 92.18B | 29.86% |
| Dec 31, 2025 | 70.99B | 46.48% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| One Global Service Provider | 11.05B |
| Chandan Healthcare | 5.82B |
| Star Imaging and Path Lab | 1.52B |
| Aspira Pathlab & Diagnostics | 1.19B |
| Invicta Diagnostic | 839.18M |
| Modern Diagnostic & Research Centre | 770.06M |
| Family Care Hospitals | 155.02M |
| Clinitech Laboratory | 91.30M |